PR Newswire - Anbogen Announces Drug Supply Collaboration with B...
TAIPEI, Sept. 27, 2024 /PRNewswire/ -- Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with Bei...
Read More

ภาษาไทย
English